154 related articles for article (PubMed ID: 15176685)
1. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma.
Kostadima E; Tsiodras S; Alexopoulos EI; Kaditis AG; Mavrou I; Georgatou N; Papamichalopoulos A
Eur Respir J; 2004 May; 23(5):714-7. PubMed ID: 15176685
[TBL] [Abstract][Full Text] [Related]
2. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma.
Amayasu H; Yoshida S; Ebana S; Yamamoto Y; Nishikawa T; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Ishizaki Y
Ann Allergy Asthma Immunol; 2000 Jun; 84(6):594-8. PubMed ID: 10875487
[TBL] [Abstract][Full Text] [Related]
3. Ineffectiveness of a four week treatment with the thromboxane synthetase inhibitor, imidazole salycilate, in reducing airway hyperresponsiveness to methacholine in asthmatics.
Peccini F; Dottorini ML; Casucci G; Mezzasoma AM; Sorbini CA; Tantucci C
Monaldi Arch Chest Dis; 1997 Apr; 52(2):130-7. PubMed ID: 9203809
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids.
Jónasson G; Carlsen KH; Blomqvist P
Eur Respir J; 1998 Nov; 12(5):1099-104. PubMed ID: 9864004
[TBL] [Abstract][Full Text] [Related]
5. The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma.
Pavord I; Mudassar T; Bennett J; Wilding P; Knox A
Eur Respir J; 1996 Feb; 9(2):217-9. PubMed ID: 8777954
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
7. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study.
Koh YY; Lee MH; Sun YH; Sung KW; Chae JH
Eur Respir J; 1997 May; 10(5):994-9. PubMed ID: 9163637
[TBL] [Abstract][Full Text] [Related]
8. Determinants of airway hyperresponsiveness in mild asthma.
Currie GP; Jackson CM; Lee DK; Lipworth BJ
Ann Allergy Asthma Immunol; 2003 May; 90(5):560-3. PubMed ID: 12775139
[TBL] [Abstract][Full Text] [Related]
9. Minor acute effect of an inhaled corticosteroid (budesonide) on bronchial hyperresponsiveness to methacholine in children with asthma.
van Essen-Zandvliet EE; Hop WC; de Jong H; Ferwerda A; Kerrebijn KF
Eur Respir J; 1993 Mar; 6(3):383-6. PubMed ID: 8472829
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two standardized methods of methacholine inhalation challenge in young adults.
Siersted HC; Walker CM; O'Shaughnessy AD; Willan AR; Wiecek EM; Sears MR
Eur Respir J; 2000 Jan; 15(1):181-4. PubMed ID: 10678643
[TBL] [Abstract][Full Text] [Related]
11. Relationship of skin-prick reactivity to aeroallergens and hyperresponsiveness to challenges with methacholine and adenosine monophosphate.
Fowler SJ; Lipworth BJ
Allergy; 2003 Jan; 58(1):46-52. PubMed ID: 12580806
[TBL] [Abstract][Full Text] [Related]
12. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
[TBL] [Abstract][Full Text] [Related]
13. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma.
Hozawa S; Haruta Y; Ishioka S; Yamakido M
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1198-202. PubMed ID: 7551370
[TBL] [Abstract][Full Text] [Related]
14. Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma.
Aubier M; Neukirch C; Peiffer C; Melac M
Allergy; 2001 Jan; 56(1):35-42. PubMed ID: 11167350
[TBL] [Abstract][Full Text] [Related]
15. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
[TBL] [Abstract][Full Text] [Related]
16. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the contributing factors to airway hyperresponsiveness by a forced oscillation technique in patients with asthma.
Imahashi Y; Kanazawa H; Ijiri N; Yoshii N; Tamagaki G; Asai K; Tochino Y; Hirata K
Osaka City Med J; 2014 Dec; 60(2):53-62. PubMed ID: 25803880
[TBL] [Abstract][Full Text] [Related]
18. Deep inspiration avoidance and methacholine response in normal subjects and patients with asthma.
Simard B; Turcotte H; Cockcroft DW; Davis BE; Boulay ME; Boulet LP
Chest; 2005 Jan; 127(1):135-42. PubMed ID: 15653974
[TBL] [Abstract][Full Text] [Related]
19. Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma.
Aldridge RE; Hancox RJ; Robin Taylor D; Cowan JO; Winn MC; Frampton CM; Town GI
Am J Respir Crit Care Med; 2000 May; 161(5):1459-64. PubMed ID: 10806139
[TBL] [Abstract][Full Text] [Related]
20. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
Prieto L; Gutiérrez V; Morales C
Eur Respir J; 1999 Jun; 13(6):1236-44. PubMed ID: 10445596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
